TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs11108495
log Bayes Factor = 0.0259079
Chromosome 12   position 96,807,917  (GRCh37) Explore rs11108495 on Ensembl!
Variant rs11108495 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T42.4 Benzodiazepines
0.000 0.898 0.102
I78.1 Naevus, nonneoplastic
0.064 0.936 0.000
I78 Diseases of capillaries
0.055 0.945 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.054 0.946 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.054 0.946 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.053 0.947 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.053 0.947 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.052 0.948 0.000
I78.0 Hereditary haemorrhagic telangiectasia
0.050 0.950 0.000
C83.3 Large cell (diffuse)
0.048 0.952 0.000
C85.1 B-cell lymphoma, unspecified
0.048 0.952 0.000
I78.8 Other diseases of capillaries
0.047 0.953 0.000
C83.0 Small cell (diffuse)
0.047 0.953 0.000
C81 Hodgkin's disease
0.047 0.953 0.000
C82.0 Small cleaved cell, follicular
0.046 0.954 0.000
C85.0 Lymphosarcoma
0.044 0.956 0.000
C88 Malignant immunoproliferative diseases
0.044 0.956 0.000
C82.2 Large cell, follicular
0.043 0.957 0.000
C95 Leukaemia of unspecified cell type
0.043 0.957 0.000
C83.5 Lymphoblastic (diffuse)
0.043 0.957 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.043 0.957 0.000
C83.1 Small cleaved cell (diffuse)
0.042 0.958 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.042 0.958 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.041 0.959 0.000
C81.1 Nodular sclerosis
0.041 0.959 0.000
C83.7 Burkitt's tumour
0.040 0.959 0.000
I78.9 Disease of capillaries, unspecified
0.039 0.961 0.000
C93 Monocytic leukaemia
0.039 0.961 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.039 0.961 0.000
C94 Other leukaemias of specified cell type
0.039 0.961 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.038 0.961 0.000
C83.6 Undifferentiated (diffuse)
0.038 0.962 0.000
C83.4 Immunoblastic (diffuse)
0.038 0.962 0.000
C83.2 Mixed small and large cell (diffuse)
0.038 0.962 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.038 0.962 0.000
C86 Other specified types of T/NK-cell lymphoma
0.038 0.962 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.038 0.962 0.000
C82.6 Cutaneous follicle centre lymphoma
0.037 0.963 0.000
C82.5 Diffuse follicle centre lymphoma
0.037 0.963 0.000
C82.4 Follicular lymphoma grade IIIb
0.037 0.963 0.000
C81.7 Other Hodgkin's disease
0.037 0.963 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.036 0.964 0.000
C95.9 Leukaemia, unspecified
0.036 0.964 0.000
C81.2 Mixed cellularity
0.035 0.965 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.033 0.966 0.000
C81.3 Lymphocytic depletion
0.033 0.966 0.000
C81.9 Hodgkin's disease, unspecified
0.034 0.966 0.000
C82.3 Follicular lymphoma grade IIIa
0.033 0.967 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.032 0.968 0.000
C88.7 Other malignant immunoproliferative diseases
0.032 0.968 0.000
C88.3 Immunoproliferative small intestinal disease
0.032 0.968 0.000
C88.2 Gamma heavy chain disease
0.032 0.968 0.000
C88.1 Alpha heavy chain disease
0.032 0.968 0.000
C95.0 Acute leukaemia of unspecified cell type
0.032 0.968 0.000
C81.0 Lymphocytic predominance
0.031 0.969 0.000
C95.7 Other leukaemia of unspecified cell type
0.031 0.969 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.031 0.969 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.031 0.969 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.030 0.969 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.030 0.970 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.030 0.970 0.000
C93.1 Chronic monocytic leukaemia
0.029 0.971 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.029 0.971 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.028 0.972 0.000
C93.9 Monocytic leukaemia, unspecified
0.028 0.972 0.000
C93.7 Other monocytic leukaemia
0.028 0.972 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.028 0.972 0.000
C93.2 Subacute monocytic leukaemia
0.028 0.972 0.000
C93.0 Acute monocytic leukaemia
0.028 0.972 0.000
C94.7 Other specified leukaemias
0.028 0.972 0.000
C94.5 Acute myelofibrosis
0.028 0.972 0.000
C94.4 Acute panmyelosis
0.028 0.972 0.000
C94.3 Mast cell leukaemia
0.028 0.972 0.000
C94.2 Acute megakaryoblastic leukaemia
0.028 0.972 0.000
C94.1 Chronic erythraemia
0.028 0.972 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.028 0.972 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.027 0.972 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.027 0.972 0.000
C86.4 Blastic NK-cell lymphoma
0.027 0.972 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.027 0.972 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.027 0.972 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.027 0.972 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.027 0.972 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.027 0.972 0.000
C96.8 Histiocytic sarcoma
0.027 0.972 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.027 0.972 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.027 0.972 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.027 0.972 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.027 0.972 0.000
C96.3 True histiocytic lymphoma
0.027 0.972 0.000
C96.2 Malignant mast cell tumour
0.027 0.972 0.000
C96.1 Malignant histiocytosis
0.027 0.972 0.000
C96.0 Letterer-Siwe disease
0.027 0.972 0.000
C91 Lymphoid leukaemia
0.025 0.975 0.000
C90.2 Plasmacytoma, extramedullary
0.024 0.976 0.000
I84.3 External thrombosed haemorrhoids
0.024 0.976 0.000
C84.0 Mycosis fungoides
0.023 0.976 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.977 0.023
C84.4 Peripheral T-cell lymphoma
0.022 0.978 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.022 0.978 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.022 0.978 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.022 0.978 0.000
C84.3 Lymphoepithelioid lymphoma
0.022 0.978 0.000
C84.2 T-zone lymphoma
0.022 0.978 0.000
C84.1 Sezary's diease
0.022 0.978 0.000
C90.1 Plasma cell leukaemia
0.021 0.978 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.020 0.980 0.000
C90.3 Solitary plasmacytoma
0.020 0.980 0.000
C91.5 Adult T-cell leukaemia
0.019 0.981 0.000
C91.9 Lymphoid leukaemia, unspecified
0.018 0.982 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.018 0.982 0.000
C91.7 Other lymphoid leukaemia
0.018 0.982 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.018 0.982 0.000
C91.3 Prolymphocytic leukaemia
0.018 0.982 0.000
C91.2 Subacute lymphocytic leukaemia
0.018 0.982 0.000
S82.30 Fracture of lower end of tibia (closed)
0.018 0.982 0.000
C91.4 Hairy-cell leukaemia
0.017 0.983 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.983 0.017
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.983 0.017
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.983 0.016
T42.3 Barbiturates
0.000 0.983 0.016
T42.2 Succinimides and oxazolidinediones
0.000 0.983 0.016
S22.30 Fracture of rib (closed)
0.000 0.984 0.016
C92 Myeloid leukaemia
0.016 0.984 0.000
C91.0 Acute lymphoblastic leukaemia
0.015 0.985 0.000
T42.1 Iminostilbenes
0.000 0.985 0.014
C84.5 Other and unspecified T-cell lymphomas
0.013 0.986 0.000
C91.1 Chronic lymphocytic leukaemia
0.012 0.988 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.988 0.012
J39.2 Other diseases of pharynx
0.012 0.988 0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.012 0.988 0.000
I70.2 Atherosclerosis of arteries of the extremities
0.012 0.988 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.988 0.012
T42.0 Hydantoin derivatives
0.000 0.988 0.011
C92.4 Acute promyelocytic leukaemia
0.011 0.988 0.000
C92.9 Myeloid leukaemia, unspecified
0.011 0.988 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.011 0.988 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.011 0.988 0.000
C92.5 Acute myelomonocytic leukaemia
0.011 0.988 0.000
C92.3 Myeloid sarcoma
0.011 0.988 0.000
C92.2 Subacute myeloid leukaemia
0.011 0.988 0.000
C92.7 Other myeloid leukaemia
0.011 0.989 0.000
I70-I79 Diseases of arteries, arterioles and capillaries
0.011 0.989 0.000
Z36.8 Other antenatal screening
0.000 0.989 0.011
I70 Atherosclerosis
0.011 0.989 0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)
0.010 0.989 0.000
I77.1 Stricture of artery
0.009 0.991 0.000
S22.3 Fracture of rib
0.000 0.991 0.009
I77 Other disorders of arteries and arterioles
0.009 0.991 0.000
I70.9 Generalised and unspecified atherosclerosis
0.009 0.991 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.991 0.009
I74 Arterial embolism and thrombosis
0.009 0.991 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.992 0.008
M19.94 Arthrosis, unspecified (Hand)
0.008 0.992 0.000
I74.5 Embolism and thrombosis of iliac artery
0.008 0.992 0.000
C90.0 Multiple myeloma
0.008 0.992 0.000
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.008 0.992 0.000
E55.9 Vitamin D deficiency, unspecified
0.000 0.992 0.008
I70.8 Atherosclerosis of other arteries
0.007 0.992 0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities
0.007 0.993 0.000
I70.0 Atherosclerosis of aorta
0.007 0.993 0.000
I70.1 Atherosclerosis of renal artery
0.007 0.993 0.000
I70.90 Generalized and unspecified atherosclerosis (without gangrene)
0.007 0.993 0.000
J01.9 Acute sinusitis, unspecified
0.007 0.993 0.000
I77.0 Arteriovenous fistula, acquired
0.007 0.993 0.000
S22.31 Fracture of rib (open)
0.000 0.993 0.007
I77.5 Necrosis of artery
0.007 0.993 0.000
I77.4 Coeliac artery compression syndrome
0.007 0.993 0.000
I77.3 Arterial fibromuscular dysplasia
0.007 0.993 0.000
I74.9 Embolism and thrombosis of unspecified artery
0.007 0.993 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.993 0.007
I70.91 Generalized and unspecified atherosclerosis (with gangrene)
0.006 0.993 0.000
S82.3 Fracture of lower end of tibia
0.006 0.993 0.000
T43.9 Psychotropic drug, unspecified
0.000 0.993 0.006
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.993 0.006
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.993 0.006
C92.1 Chronic myeloid leukaemia
0.006 0.994 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.994 0.006
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere
0.006 0.994 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.994 0.006
I77.8 Other specified disorders of arteries and arterioles
0.006 0.994 0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified
0.006 0.994 0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta
0.006 0.994 0.000
H26.8 Other specified cataract
0.006 0.994 0.000
I79.1 Aortitis in diseases classified elsewhere
0.006 0.994 0.000
I79.0 Aneurysm of aorta in diseases classified elsewhere
0.006 0.994 0.000
N05.9 Unspecified
0.006 0.994 0.000
N81.3 Complete uterovaginal prolapse
0.000 0.994 0.006
T43.6 Psychostimulants with abuse potential
0.000 0.994 0.006
Z01.9 Special examination, unspecified
0.006 0.994 0.000
I70.81 Atherosclerosis of other arteries (with gangrene)
0.005 0.994 0.000
Z01.6 Radiological examination, not elsewhere classified
0.006 0.994 0.000
I74.0 Embolism and thrombosis of abdominal aorta
0.005 0.994 0.000
I70.01 Atherosclerosis of aorta (with gangrene)
0.005 0.994 0.000
I74.8 Embolism and thrombosis of other arteries
0.005 0.994 0.000
I77.2 Rupture of artery
0.005 0.994 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.995 0.005
I70.11 Atherosclerosis of renal artery (with gangrene)
0.005 0.995 0.000
N42.1 Congestion and haemorrhage of prostate
0.005 0.995 0.000
I77.9 Disorder of arteries and arterioles, unspecified
0.005 0.995 0.000
I73 Other peripheral vascular diseases
0.005 0.995 0.000
Z36 Antenatal screening
0.000 0.995 0.005
I79.2 Peripheral angiopathy in diseases classified elsewhere
0.005 0.995 0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods
0.000 0.995 0.005
N42.0 Calculus of prostate
0.005 0.995 0.000
I70.80 Atherosclerosis of other arteries (without gangrene)
0.005 0.995 0.000
N05 Unspecified nephritic syndrome
0.005 0.995 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.995 0.005
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.995 0.005
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.005 0.995 0.000
I73.8 Other specified peripheral vascular diseases
0.005 0.995 0.000
Z01.4 Gynaecological examination (general)(routine)
0.005 0.995 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.995 0.005
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.995 0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.995 0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.995 0.005
T45.0 Antiallergic and antiemetic drugs
0.000 0.995 0.005
I77.6 Arteritis, unspecified
0.005 0.995 0.000
Z01 Other special examinations and investigations of persons without complaint or reported diagnosis
0.005 0.995 0.000
G99.2 Myelopathy in diseases classified elsewhere
0.000 0.995 0.005
J01 Acute sinusitis
0.005 0.995 0.000
I70.00 Atherosclerosis of aorta (without gangrene)
0.005 0.995 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.995 0.005
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.995 0.005
I72 Other aneurysm
0.005 0.995 0.000
O70.2 Third degree perineal laceration during delivery
0.000 0.995 0.005
I70.10 Atherosclerosis of renal artery (without gangrene)
0.004 0.996 0.000
N05.2 Diffuse membranous glomerulonephritis
0.004 0.996 0.000
N05.8 Other
0.004 0.996 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.004 0.996 0.000
Z36.2 Other antenatal screening based on amniocentesis
0.000 0.996 0.004
Z36.0 Antenatal screening for chromosomal anomalies
0.000 0.996 0.004
N42 Other disorders of prostate
0.004 0.996 0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities
0.004 0.996 0.000
S82.31 Fracture of lower end of tibia (open)
0.004 0.996 0.000
I72.9 Aneurysm of unspecified site
0.004 0.996 0.000
J01.2 Acute ethmoidal sinusitis
0.004 0.996 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.996 0.004
T37.5 Antiviral drugs
0.000 0.996 0.004
T37.4 Anthelminthics
0.000 0.996 0.004
T37.3 Other antiprotozoal drugs
0.000 0.996 0.004
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.996 0.004
T37.1 Antimycobacterial drugs
0.000 0.996 0.004
T37.0 Sulphonamides
0.000 0.996 0.004
S22 Fracture of rib(s), sternum and thoracic spine
0.000 0.996 0.004
S22.00 Fracture of thoracic vertebra (closed)
0.000 0.996 0.004
Z01.2 Dental examination
0.004 0.996 0.000
S22.0 Fracture of thoracic vertebra
0.000 0.996 0.004
I73.1 Thromboangiitis obliterans [Buerger]
0.004 0.996 0.000
Z36.5 Antenatal screening for isoimmunisation
0.000 0.996 0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.996 0.004
N05.6 Dense deposit disease
0.004 0.996 0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.004 0.996 0.000
N05.0 Minor glomerular abnormality
0.004 0.996 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.996 0.004
T45.8 Other primarily systemic and haematological agents
0.000 0.996 0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.996 0.004
T45.6 Fibrinolysis-affecting drugs
0.000 0.996 0.004
T45.4 Iron and its compounds
0.000 0.996 0.004
T45.3 Enzymes, not elsewhere classified
0.000 0.996 0.004
N42.2 Atrophy of prostate
0.004 0.996 0.000
J01.1 Acute frontal sinusitis
0.004 0.996 0.000
T36 Poisoning by systemic antibiotics
0.000 0.996 0.004
Z01.3 Examination of blood pressure
0.004 0.996 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.996 0.004
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.996 0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.996 0.004
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.996 0.004
T44.0 Anticholinesterase agents
0.000 0.996 0.004
Z01.1 Examination of ears and hearing
0.004 0.996 0.000
H02.5 Other disorders affecting eyelid function
0.000 0.996 0.004
N05.7 Diffuse crescentic glomerulonephritis
0.004 0.996 0.000
Z01.0 Examination of eyes and vision
0.004 0.996 0.000
K86.9 Disease of pancreas, unspecified
0.004 0.996 0.000
E55 Vitamin D deficiency
0.000 0.996 0.004
Z36.1 Antenatal screening for raised alphafetoprotein level
0.000 0.996 0.004
C78.2 Secondary malignant neoplasm of pleura
0.004 0.996 0.000
N05.1 Focal and segmental glomerular lesions
0.004 0.996 0.000
T41.5 Therapeutic gases
0.000 0.996 0.004
T41.4 Anaesthetic, unspecified
0.000 0.996 0.004
T41.3 Local anaesthetics
0.000 0.996 0.004
T41.2 Other and unspecified general anaesthetics
0.000 0.996 0.004
T41.1 Intravenous anaesthetics
0.000 0.996 0.004
T41.0 Inhaled anaesthetics
0.000 0.996 0.004
J01.8 Other acute sinusitis
0.004 0.996 0.000
T45.5 Anticoagulants
0.000 0.996 0.004
T45.2 Vitamins, not elsewhere classified
0.000 0.996 0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.996 0.004
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.996 0.004
T47.7 Emetics
0.000 0.996 0.004
T47.6 Antidiarrhoeal drugs
0.000 0.996 0.004
T47.5 Digestants
0.000 0.996 0.004
T47.4 Other laxatives
0.000 0.996 0.004
T47.3 Saline and osmotic laxatives
0.000 0.996 0.004
T47.2 Stimulant laxatives
0.000 0.996 0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.996 0.004
T48.4 Expectorants
0.000 0.996 0.004
T48.3 Antitussives
0.000 0.996 0.004
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.996 0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.996 0.004
T48.0 Oxytocic drugs
0.000 0.996 0.004
K09.1 Developmental (nonodontogenic) cysts of oral region
0.000 0.996 0.004
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.996 0.004
T47.0 Histamine H(2)-receptor antagonists
0.000 0.996 0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.996 0.004
J01.4 Acute pansinusitis
0.004 0.996 0.000
J01.3 Acute sphenoidal sinusitis
0.004 0.996 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.996 0.004
T48.5 Anti-common-cold drugs
0.000 0.996 0.003
K43.9 Ventral hernia without obstruction or gangrene
0.000 0.996 0.004
T49.9 Topical agent, unspecified
0.000 0.996 0.003
T49.8 Other topical agents
0.000 0.996 0.003
T49.7 Dental drugs, topically applied
0.000 0.996 0.003
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.996 0.003
T49.5 Ophthalmological drugs and preparations
0.000 0.996 0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.996 0.003
T49.3 Emollients, demulcents and protectants
0.000 0.996 0.003
T49.2 Local astringents and local detergents
0.000 0.996 0.003
T49.1 Antipruritics
0.000 0.996 0.003
I72.6 Aneurysm and dissection of vertebral artery
0.003 0.996 0.000
I72.5 Aneurysm and dissection of other precerebral arteries
0.003 0.996 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.996 0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.996 0.004
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods
0.000 0.996 0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.996 0.003
I72.2 Aneurysm of renal artery
0.003 0.997 0.000
C92.0 Acute myeloid leukaemia
0.003 0.997 0.000
N42.3 Dysplasia of prostate
0.003 0.997 0.000
K09.8 Other cysts of oral region, not elsewhere classified
0.000 0.997 0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.997 0.003
I72.1 Aneurysm of artery of upper extremity
0.003 0.997 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.997 0.003
J01.0 Acute maxillary sinusitis
0.003 0.997 0.000
J39 Other diseases of upper respiratory tract
0.003 0.997 0.000
S22.9 Fracture of bony thorax, part unspecified
0.000 0.997 0.003
S22.8 Fracture of other parts of bony thorax
0.000 0.997 0.003
S22.01 Fracture of thoracic vertebra (open)
0.000 0.997 0.003
Z01.7 Laboratory examination
0.003 0.997 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.997 0.003
T38.9 Other and unspecified hormone antagonists
0.000 0.997 0.003
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.997 0.003
T38.7 Androgens and anabolic congeners
0.000 0.997 0.003
T38.5 Other oestrogens and progestogens
0.000 0.997 0.003
T38.4 Oral contraceptives
0.000 0.997 0.003
T38.2 Antithyroid drugs
0.000 0.997 0.003
T38.0 Glucocorticoids and synthetic analogues
0.000 0.997 0.003
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)
0.000 0.997 0.003
C78.7 Secondary malignant neoplasm of liver
0.003 0.997 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.997 0.003
T36.9 Systemic antibiotic, unspecified
0.000 0.997 0.003
T36.8 Other systemic antibiotics
0.000 0.997 0.003
T36.7 Antifungal antibiotics, systemically used
0.000 0.997 0.003
T36.6 Rifamycins
0.000 0.997 0.003
T36.5 Aminoglycosides
0.000 0.997 0.003
T36.4 Tetracyclines
0.000 0.997 0.003
T36.2 Chloramphenicol group
0.000 0.997 0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.997 0.003
S32.40 Fracture of acetabulum (closed)
0.000 0.997 0.003
K09 Cysts of oral region, not elsewhere classified
0.000 0.997 0.003
S22.5 Flail chest
0.000 0.997 0.003
E55.0 Rickets, active
0.000 0.997 0.003
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.003 0.997 0.000
K85.1 Biliary acute pancreatitis
0.003 0.997 0.000
T36.3 Macrolides
0.000 0.997 0.003
Y42.7 Androgens and anabolic congeners
0.000 0.997 0.003
I72.0 Aneurysm of carotid artery
0.003 0.997 0.000
I72.3 Aneurysm of iliac artery
0.003 0.997 0.000
T43.2 Other and unspecified antidepressants
0.000 0.997 0.003
T50.7 Analeptics and opioid receptor antagonists
0.000 0.997 0.003
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.997 0.003
T50.5 Appetite depressants
0.000 0.997 0.003
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.997 0.003
T50.1 Loop [high-ceiling] diuretics
0.000 0.997 0.003
T50.0 Mineralocorticoids and their antagonists
0.000 0.997 0.003
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.003 0.997 0.000
T50.8 Diagnostic agents
0.000 0.997 0.003
J39.1 Other abscess of pharynx
0.003 0.997 0.000
K09.0 Developmental odontogenic cysts
0.000 0.997 0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.997 0.003
T40.8 Lysergide [LSD]
0.000 0.997 0.003
T40.7 Cannabis (derivatives)
0.000 0.997 0.003
T40.5 Cocaine
0.000 0.997 0.003
T40.3 Methadone
0.000 0.997 0.003
T40.1 Heroin
0.000 0.997 0.003
T40.0 Opium
0.000 0.997 0.003
T40.6 Other and unspecified narcotics
0.000 0.997 0.003
C78.0 Secondary malignant neoplasm of lung
0.003 0.997 0.000
S27.2 Traumatic heamopneumothorax
0.000 0.997 0.003
I72.4 Aneurysm of artery of lower extremity
0.003 0.997 0.000
K91.4 Colostomy and enterostomy malfunction
0.003 0.997 0.000
N42.8 Other specified disorders of prostate
0.003 0.997 0.000
S22.1 Multiple fractures of thoracic spine
0.000 0.997 0.003
T40.4 Other synthetic narcotics
0.000 0.997 0.003
V48.4 Person injured while boarding or alighting
0.003 0.997 0.000
B35.3 Tinea pedis
0.000 0.997 0.003
Q05.9 Spina bifida, unspecified
0.003 0.997 0.000
Z90.5 Acquired absence of kidney
0.003 0.997 0.000
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified
0.003 0.997 0.000
S22.81 Fracture of other parts of bony thorax (open)
0.000 0.997 0.002
S22.80 Fracture of other parts of bony thorax (closed)
0.000 0.997 0.002
S22.91 Fracture of bony thorax, part unspecified (open)
0.000 0.997 0.002
S22.90 Fracture of bony thorax, part unspecified (closed)
0.000 0.997 0.002
M31.6 Other giant cell arteritis
0.000 0.997 0.003
S22.2 Fracture of sternum
0.000 0.997 0.003
J39.0 Retropharyngeal and parapharyngeal abscess
0.003 0.997 0.000
D16.1 Short bones of upper limb
0.003 0.997 0.000
N42.9 Disorder of prostate, unspecified
0.003 0.997 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.997 0.003
T50.4 Drugs affecting uric acid metabolism
0.000 0.997 0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.997 0.002
D32.0 Cerebral meninges
0.003 0.997 0.000
I72.8 Aneurysm of other specified arteries
0.002 0.997 0.000
K09.2 Other cysts of jaw
0.000 0.997 0.002
S22.51 Flail chest (open)
0.000 0.998 0.002
C78.1 Secondary malignant neoplasm of mediastinum
0.002 0.998 0.000
I86.1 Scrotal varices
0.002 0.998 0.000
S02.50 Fracture of tooth (closed)
0.002 0.998 0.000
K80.4 Calculus of bile duct with cholecystitis
0.000 0.998 0.002
S27 Injury of other and unspecified intrathoracic organs
0.000 0.998 0.002
C78.4 Secondary malignant neoplasm of small intestine
0.002 0.998 0.000
K43.0 Ventral hernia with obstruction, without gangrene
0.000 0.998 0.002
S22.4 Multiple fractures of ribs
0.000 0.998 0.002
S82.20 Fracture of shaft of tibia (closed)
0.000 0.998 0.002
K43 Ventral hernia
0.000 0.998 0.002
J39.9 Disease of upper respiratory tract, unspecified
0.002 0.998 0.000
T36.0 Penicillins
0.000 0.998 0.002
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.002 0.998 0.000
F40.2 Specific (isolated) phobias
0.000 0.998 0.002
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)
0.000 0.998 0.002
K09.9 Cyst of oral region, unspecified
0.000 0.998 0.002
S20-S29 Injuries to the thorax
0.000 0.998 0.002
S22.11 Multiple fractures of thoracic spine (open)
0.000 0.998 0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.998 0.002
S22.50 Flail chest (closed)
0.000 0.998 0.002
S22.21 Fracture of sternum (open)
0.000 0.998 0.002
S27.3 Other injuries of lung
0.000 0.998 0.002
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.002 0.998 0.000
A40.8 Other streptococcal septicaemia
0.000 0.998 0.002
F33.1 Recurrent depressive disorder, current episode moderate
0.002 0.998 0.000
K56.6 Other and unspecified intestinal obstruction
0.000 0.998 0.002
F42.9 Obsessive-compulsive disorder, unspecified
0.000 0.998 0.002
Q05 Spina bifida
0.002 0.998 0.000
Q05.4 Unspecified spina bifida with hydrocephalus
0.002 0.998 0.000
S27.0 Traumatic pneumothorax
0.000 0.998 0.002
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.998 0.002
D41.4 Bladder
0.002 0.998 0.000
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral
0.002 0.998 0.000
H90.5 Sensorineural hearing loss, unspecified
0.000 0.998 0.002
S27.9 Injury of unspecified intrathoracic organ
0.000 0.998 0.002
S27.7 Multiple injuries of intrathoracic organs
0.000 0.998 0.002
S27.6 Injury of pleura
0.000 0.998 0.002
S27.5 Injury of thoracic trachea
0.000 0.998 0.002
S27.4 Injury of bronchus
0.000 0.998 0.002
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess
0.002 0.998 0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)
0.000 0.998 0.002
S22.41 Multiple fractures of ribs (open)
0.000 0.998 0.002
G60.0 Hereditary motor and sensory neuropathy
0.002 0.998 0.000
K43.7 Other and unspecified ventral hernia with gangrene
0.000 0.998 0.002
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene
0.000 0.998 0.002
K43.5 Parastomal hernia without obstruction or gangrene
0.000 0.998 0.002
K43.4 Parastomal hernia with gangrene
0.000 0.998 0.002
K43.3 Parastomal hernia with obstruction, without gangrene
0.000 0.998 0.002
K43.2 Incisional hernia without obstruction or gangrene
0.000 0.998 0.002
K43.1 Ventral hernia with gangrene
0.000 0.998 0.002
S23 Dislocation, sprain and strain of joints and ligaments of thorax
0.000 0.998 0.002
D69.6 Thrombocytopenia, unspecified
0.002 0.998 0.000
I73.0 Raynaud's syndrome
0.002 0.998 0.000
N83.3 Acquired atrophy of ovary and Fallopian tube
0.000 0.998 0.002
G99 Other disorders of nervous system in diseases classified elsewhere
0.000 0.998 0.002
M06.34 Rheumatoid nodule (Hand)
0.002 0.998 0.000
J39.8 Other specified diseases of upper respiratory tract
0.002 0.998 0.000
S20.8 Superficial injuries of other and unspecified parts of thorax
0.000 0.998 0.002
Z01.5 Diagnostic skin and sensitisation tests
0.001 0.998 0.001
S28 Crushing injury of thorax and traumatic amputation of part of thorax
0.000 0.998 0.002
S26 Injury of heart
0.000 0.998 0.002
S25 Injury of blood vessels of thorax
0.000 0.998 0.002
S24 Injury of nerves and spinal cord at thorax level
0.000 0.998 0.002
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)
0.000 0.998 0.002
S27.8 Injury of other specified intrathoracic organs
0.000 0.998 0.002
S27.31 Other injuries of lung (with open wound into thoracic cavity)
0.000 0.998 0.002
S27.1 Traumatic haemothorax
0.000 0.998 0.002
S20 Superficial injury of thorax
0.000 0.998 0.002
M06.33 Rheumatoid nodule (Forearm)
0.002 0.998 0.000
H53.0 Amblyopia ex anopsia
0.002 0.998 0.000
S21 Open wound of thorax
0.000 0.998 0.002
B35.1 Tinea unguium
0.000 0.998 0.002
Q05.8 Sacral spina bifida without hydrocephalus
0.002 0.998 0.000
Q05.7 Lumbar spina bifida without hydrocephalus
0.002 0.998 0.000
Q05.6 Thoracic spina bifida without hydrocephalus
0.002 0.998 0.000
Q05.5 Cervical spina bifida without hydrocephalus
0.002 0.998 0.000
Q05.3 Sacral spina bifida with hydrocephalus
0.002 0.998 0.000
Q05.2 Lumbar spina bifida with hydrocephalus
0.002 0.998 0.000
Q05.1 Thoracic spina bifida with hydrocephalus
0.002 0.998 0.000
Q05.0 Cervical spina bifida with hydrocephalus
0.002 0.998 0.000
S21.1 Open wound of front wall of thorax
0.000 0.998 0.002
S82.10 Fracture of upper end of tibia (closed)
0.000 0.998 0.002
I73.9 Peripheral vascular disease, unspecified
0.002 0.998 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.998 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.